Skip to main content

Helicos to Place Single-Molecule Sequencer at Broad Institute at No Cost

NEW YORK (GenomeWeb News) - Helicos BioSciences said today in a filing with the US Securities and Exchange Commission that it is preparing to place a Helicos Genetic Analysis System at the Broad Institute.
The company said that it is providing the system to the Broad at no cost and that it expects to install it in early 2009.
Helicos said that it has recently improved its single-molecule sequencing chemistry and other aspects of the system so that it now generates approximately 100 megabases to 140 megabases per hour — an improvement over the 50 megabases per hour that the company reported in its third-quarter earnings statement.
The company said that the system provides median read lengths of 33 bases and has an approximate total error rate of 5 percent.
Helicos has also placed its sequencer at Stanford University and genomic services firm Expression Analysis, but the company has not disclosed the financial terms for either of those agreements.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.